Home › Markets › Health Care › NXTC

NextCure Inc. (NXTC)

NXTC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$6.28
-5.42% on the day
Market cap
$28.7M
Nano cap
Revenue
No annual revenue filed since the period ending 2020-12-31
Net income
No annual revenue filed since the period ending 2020-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerNXTC on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2019
SEC CIK0001661059
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue filed since the period ending 2020-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-12-19
Latest annual report10-K2026-03-05
Latest quarterly / interim10-Q2026-08-06
Latest current report8-K2026-09-25
Latest proxyDEFA14A2026-04-24

Source: SEC EDGAR submissions feed, 390 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RNAZTransCode Therapeutics Inc.$1.68+3.07%$28.4M
MIRAMIRA Pharmaceuticals Inc.$0.6664-5.53%$28.0M
IGCIGC Pharma Inc.$0.2650-3.99%$27.4M
IMMPImmutep Limited$3.57-2.73%$26.3M
ATNMActinium Pharmaceuticals Inc. (Delaware)$0.9995-5.71%$31.4M
ABVCABVC BioPharma Inc.$0.9790-0.08%$26.1M
RMTIRockwell Medical Inc.$7.85+3.70%$31.6M
BCTXBriaCell Therapeutics Corp. Common Shares$3.71-4.13%$32.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier